What is GNPX's current stock price?

As of now, GNPX is trading at $6.27, with a daily change of -5.57%.

What are the risks associated with GNPX stock?

GNPX Key risk is its Moderate Risk Level, .

What is GNPX next earnings date?

GNPX next earnings report is yet to be scheduled.

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Earnings Calendar Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

GNPX Stock Analysis & IQ Rating | Genprex

GNPX

Genprex

$6.27

-$0.37 | -5.57%

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Earnings

Headlines

52W High

$ 129.5

MKT CAP

$ 7.76M

52W Low

$ 6.18

VOL

$ 185.30K

P/E Ratio

N/A

AVG VOL

$ 1.17M

RSI

TREND

GNPX Stock IQ

Login to see Genprex (GNPX) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

GNPX Target Price

Login to display

Chart

$0.19 (+3200.00%)

$0.22 (+2750.00%)

$0.32 (+1859.38%)

$1.6 (+291.88%)

1year

6month

3month

1month

GNPX Risk Level

GNPX has Moderate Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk

Risks Indicators

Price under $5

High volatilty

LOW

HIGH

GNPX Analysts Opinion

GNPX overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

GNPX Analysts Opinion

GNPX Analysts opinion is negative and it remained unchanged from the past 3 months

GNPX Street Consensus

Analysts perspectives on the stock desirability, trend direction, and growth potential.

82%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

NA

100%

NA

GNPX Street Opinion

GNPX Street view is extremely bullish and have negative views on the near-term outlook

GNPX Performance Sentiment

Sentiments overview associated with GNPX events and the stock performance.

82%

18%

Positive

Negative

9 out of 11
events present

2 out of 11
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels.

Login to display

Support
Price

$9.61

Resistance
Price

$0.17

Current Price Range

$11.50

Show methods +

GNPX Earnings

The TTM reflects 12-month period, providing review of GNPX financial performance.

Millions of Dollars

TTM

2024

2023

CAGR

Total Revenue

-

Operating Exp

21

31

-17.69%

Operating Inc

-21

-31

-

Net Interest Inc

-

Interest Inc

-

Other Inc Exp

-

EPS Growth

-10.69

-5.34

-22.56

-

GNPX Financial Health

The company financial health is gradually deteriorating, indicating rising risks and weakening fundamentals

Financial Score

2.36

GNPX Latest Analysis +

FAQ About GNPX Stock Insights

What is GNPX current stock price?

What are GNPX stock strengths?

What risks are associated with GNPX stock?

When is GNPX next earnings report?

What is GNPX market cap and volume?

What is GNPX's current Stock IQ?

Should I buy GNPX stock right now?

Is GNPX a Strong Buy right now?

What does a 'Strong Buy' rating mean for GNPX?

What does a 'Strong Sell' rating mean for GNPX?

What factors influence GNPX's Stock IQ?

Explore our GNPX Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored GNPX Stock Strategies
Effective Risk Management

FIND US ON

Receive our GNPX Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

GNPX

Genprex

Current Price

$6.27

-$0.37 | -5.57%

52W High

$ 129.5

MKT CAP

$ 7.76M

52W Low

$ 6.18

VOL

$ 185.30K

P/E Ratio

N/A

AVG VOL

$ 1.17M

RSI

TREND

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Earnings

Target Price

Login to display

Not Enough Information

Stock Insights

Not Enough Information

GNPX Stock IQ

Login to unlock Genprex (GNPX) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

Chart

$0.19 (+3200.00%)

$0.22 (+2750.00%)

$0.32 (+1859.38%)

$1.6 (+291.88%)

1year

6month

3month

1month

GNPX Analysts Opinion

GNPX Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
menu Hover over the category for more information

GNPX Analysts Opinion

GNPX Analysts opinion is negative and it remained unchanged from the past 3 months

GNPX Street Consensus

Analysts perspectives on the stock desirability, trend direction, and growth potential.

82%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

NA

100%

NA

GNPX Street Opinion

GNPX Street view is extremely bullish and have negative views on the near-term outlook

GNPX Risk Level

GNPX has Moderate Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk

Risks Indicators

Price under $5

High volatilty

LOW

HIGH

GNPX Performance Sentiment

Sentiments overview associated with GNPX events and the stock performance.

82%

18%

Positive

Negative

9 out of 11
events present

2 out of 11
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels.

Login to display

Support
Price

$9.61

Resistance
Price

$0.17

Current Price Range

$11.50

Show methods +

GNPX Earnings

The TTM data reflects the most recent 12-month period, providing overview of GNPX financial performance.

Millions of Dollars

TTM

2024

2023

CAGR

Total Revenue

-

Operating Exp

21

31

-17.69%

Operating Inc

-21

-31

-

Net Interest Inc

-

Interest Inc

-

Other Inc Exp

-

EPS Growth

-10.69

-5.34

-22.56

-

GNPX Financial Health

The company financial health is gradually deteriorating, indicating rising risks and weakening fundamentals

Financial Score

2.36

GNPX Latest Analysis

Genprex Announces Registered Direct Offering of up to $10.0 Million Priced At-The-Market Under Nasdaq Rules. $3.4 million upfront with up to an additional $6.6 million of potential aggregate gross proceeds upon the exercise in full of short-term warrants AUSTIN Texas Oct. 28 2025 /PRNewswire/ -- Genprex Inc. (Genprex or the Company) (NASDAQ: GNPX) a clinical-stage gene therapy company...

Tue Oct 28, 2025

$6.99 | -20.11%

Activity

Genprex stock soars after positive preclinical lung cancer treatment data.

Tue Oct 28, 2025

$6.99 | -20.11%

Momentum

Genprex launches offering to raise up to $8.1M.

Thu Oct 23, 2025

$9.16 | -16.42%

Activity

Genprex stock soars after positive preclinical lung cancer treatment data.

Thu Oct 23, 2025

$9.16 | -16.42%

Momentum

Genprex (GNPX) Shares Jump 41% After Hours Following New Cancer Therapy Data. ) shares rose 41.39% to $0.36 in after-hours trading on Tuesday.Check out the current price of .The Texas-based company announced on Tuesday that its research collaborators will present preclinical data at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics taking place from October 22 to October 26 in Boston.The presentation covers “.

Wed Oct 15, 2025

$0.84 | +232.67%

Momentum

Genprex Collaborators to Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy for the Treatment of Lung Cancer at the 2025 AACR-NCI-EROTC International Conference on Molecular Targets and Cancer Therapeutics. Reqorsa®. Gene Therapy is a Potential Treatment for ALK-EML4 Positive Translocated Non-Small Cell Lung Cancer (".Genprex". or the ".Company".) (NASDAQ: ) a clinical-stage gene therapy company focused on developing life-changing therapies for patients with ca

Tue Oct 14, 2025

$0.25 | +30.15%

Activity

Momentum

Discover GNPX Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of GNPX. We're here to help you make informed investment decisions today.

FIND US ON

Receive our GNPX Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

GNPX Stock trends

GNPX Stock performance

GNPX Stock analysis

GNPX investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing GNPX

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing GNPX

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

GNPX Stock Analysis & IQ Rating | Genprex

GNPX Stock IQ

GNPX Target Price

GNPX Risk Level

GNPX Analysts Opinion

GNPX Street Consensus

GNPX Performance Sentiment

Technical Price Levels

GNPX Financial Health

Explore our GNPX Stock insights

Receive our GNPX Daily Alerts

GNPX Stock IQ

GNPX Street Consensus

GNPX Risk Level

Technical Price Levels

Discover GNPX Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of GNPX. We're here to help you make informed investment decisions today.

Receive our GNPX Daily Alerts

GNPX Runner Alarm